Comparative effectiveness of thromboprophylaxis in acutely ill medical patients across the US acute hospital setting

被引：0
|
作者：
Huang, W. [1 ]
Anderson, F. A. [1 ]
Cohen, A. T. [2 ]
机构：
[1] Univ Massachusetts, Ctr Outcomes Res, Sch Med, Amherst, MA 01003 USA
[2] Guys Kings & St Thomas Sch Med, Dept Vasc Med, London, England
来源：
JOURNAL OF THROMBOSIS AND HAEMOSTASIS | 2011年 / 9卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O-TH-086
引用
收藏
页码：749 / 749
页数：1
相关论文
共 50 条
  • [21] Extended thromboprophylaxis in acutely ill medical patients with prolonged immobilisation: The EXCLAIM study.
    Hull, R
    Schellong, S
    Tapson, V
    Yusen, R
    Monreal, M
    Samama, MM
    Turpie, AGG
    Wildgoose, P
    Cort, S
    BLOOD, 2002, 100 (11) : 127B - 127B
  • [22] Rivaroxaban for extended thromboprophylaxis in acutely ill medical patients 75 years of age or older
    Ageno, Walter
    Lopes, Renato D.
    Goldin, Mark
    Yusen, Roger D.
    Albers, Gregory W.
    Elliott, Gregory C.
    Halperin, Jonathan L.
    Hiatt, William R.
    Maynard, Gregory
    Steg, Philippe Gabriel
    Weitz, Jeffrey, I
    Suh, Eunyoung
    Lu, Wentao
    Barnathan, Elliot S.
    Raskob, Gary E.
    Spyropoulos, Alex C.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2021, 19 (11) : 2772 - 2780
  • [23] Estimation of Acutely Ill Medical Patients at Venous Thromboembolism Risk Eligible for Extended Thromboprophylaxis Using APEX Criteria in US Hospitals
    Martin, Anne-Celine
    Huang, Wei
    Goldhaber, Samuel Z.
    Hull, Russell D.
    Hernandez, Adrian F.
    Gibson, Charles-Michael
    Anderson, Frederick A.
    Cohen, Alexander T.
    CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS, 2019, 25
  • [24] The EXCLAIM study: Extended thromboprophylaxis with enoxaparin in acutely ill medical patients with restricted mobility.
    Hull, R
    Tapson, VF
    Schellong, S
    Yusen, RD
    Monreal, M
    Samama, MM
    Turpie, AGG
    Wildgoose, P
    Cort, S
    BLOOD, 2003, 102 (11) : 125B - 125B
  • [25] Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
    Cohen, Alexander Thomas
    Spiro, Theodore Erich
    Buller, Harry Roger
    Haskell, Lloyd
    Hu, Dayi
    Hull, Russell
    Mebazaa, Alexandre
    Merli, Geno
    Schellong, Sebastian
    Spyropoulos, Alex
    Tapson, Victor
    JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2011, 31 (04) : 407 - 416
  • [26] Extended-duration rivaroxaban thromboprophylaxis in acutely ill medical patients: MAGELLAN study protocol
    Alexander Thomas Cohen
    Theodore Erich Spiro
    Harry Roger Büller
    Lloyd Haskell
    Dayi Hu
    Russell Hull
    Alexandre Mebazaa
    Geno Merli
    Sebastian Schellong
    Alex Spyropoulos
    Victor Tapson
    Journal of Thrombosis and Thrombolysis, 2011, 31 : 407 - 416
  • [27] Thromboprophylaxis of venous thromboembolism in acutely ill medical patients with enoxaparin - Consistency of treatment effect across disease groups: The MEDENOX trial.
    Cohen, A
    BLOOD, 1999, 94 (10) : 103B - 103B
  • [28] Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
    Nanna Freund
    Jonas E. Sabroe
    Peter Bytzer
    Søren M. Madsen
    Advances in Therapy, 2018, 35 : 1873 - 1883
  • [29] Compliance with Guidelines on Thromboprophylaxis for Acutely Admitted Medical Patients
    Freund, Nanna
    Sabroe, Jonas E.
    Bytzer, Peter
    Madsen, Soren M.
    ADVANCES IN THERAPY, 2018, 35 (11) : 1873 - 1883
  • [30] Utilization of venous thromboprophylaxis in acutely ill medical patients in Canada: Results from the Canadian Registry (CURVE).
    Panju, A
    Kahn, S
    Geerts, W
    Pineo, G
    Desjardins, L
    Turpie, A
    Glezer, S
    Sebaldt, R
    BLOOD, 2003, 102 (11) : 498A - 498A
12345